Search

everythinglearnresearchcommunity

for

Search:↓

Most women with Polycystic Ovary Syndrome (PCOS) have skin issues like excessive hair, acne, or hair loss. Hormone imbalances are common, and age, certain hormones, and hormone ratios can predict acne. Obesity, infertility, and high cholesterol are also common in these women.

Most women with PCOS have insulin resistance, especially those with phenotype B.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

ME1 and PPAR signaling may influence hair loss in androgenetic alopecia.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Adults should not consume more than 255 micrograms of selenium per day to avoid risk of hair loss and other side effects.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

New information suggests that metformin might help more women with PCOS and infertility, not just those with glucose issues.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Maritime pine bark has various chemical components useful for different industrial uses.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Women with PCOS are much more likely to experience depression.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Non-surgical procedures can help reduce wrinkles and stimulate skin repair by understanding skin aging at the molecular level.

Some women with PCOS have rare genetic variants linked to the condition.